Eli Lilly Alzheimer's treatment solanezumab failed to slow disease progression

Solanezumab's failure is a blow to efforts to treat Alzheimer's in people who have not yet shown clinical symptoms.

from Health and Science https://ift.tt/64jwDGs
https://ift.tt/g7y6jew
https://ift.tt/s6yNOmM